Listen on the go
CORRECT!
Next question
touchONCOLOGY touchONCOLOGY
Supportive Cancer Care

Andreas Charalambous, ESMO 2019 – EONS Safety Manifesto

Published Online: October 11th 2019

Andreas Charalambous, President of the European Oncology Nursing Society (EONS), joined us at ESMO 2019 to highlight the work EONS have been doing around safety and specifically their Safety Manifesto.

Questions
1. How can cancer nurses reduce the risk of harm to patients? (0:05)
2. What general precautions should cancer nurses take in terms of cytotoxic and radiation therapies if they are planning to become pregnant or are pregnant and/or breastfeeding? (1:00)
3. What should cancer nurses be aware of in terms of the appropriate use of personal protective equipment? (2:00)
4. What are the five Rs of medication administration? (2:45)
5. How should a cancer nurse deal with adverse events, including risks and near misses? (3:12)

Filmed at the European Society for Medical Oncology (ESMO) Congress 2019, Barcelona, Spain.

touchONCOLOGY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.

Share this Video
Related Videos In Supportive Cancer Care
Supportive Cancer Care
Professor D’Ugo: Don’t Miss Out on Registering for the ESSO 40!

Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO), shares what we can look forward to at the annual meeting in November!

Supportive Cancer Care
Domenico D’Ugo, ESSO 40: Hot Topics, What to Expect and Why Should HCPs Register

touchONCOLOGY were delighted to speak with Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO) one our media partners. He discusses why healthcare professionals should register and attend the ESSO 40 conference in November 2021 in Lisbon and what we can look forward to. Questions 1. What can we expect from ESSO […]

Supportive Cancer Care
Professor Domenico D’Ugo: Current Initiatives at ESSO and Looking to the Future

Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO) one our valued media partners at touchONCOLOGY, discusses the latest from the society and his hopes for oncology management post-COVID19 in 2022. Questions 1. Please tell us about any initiatives that ESSO are currently working on? (00:15-02:24) 2. What can we expect in […]

Trending In Supportive Cancer Care:

Professor D’Ugo: Don’t Miss Out on Registering for the ESSO 40!
Supportive Cancer Care
    • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72